Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | +9.94% | -21.68% | +16.81% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
Financials (USD)
Sales 2024 * | 35.17M | Sales 2025 * | 35.71M | Capitalization | 332M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -99M | EV / Sales 2024 * | 6.82 x |
Net cash position 2024 * | 91.88M | Net cash position 2025 * | 44.36M | EV / Sales 2025 * | 8.04 x |
P/E ratio 2024 * |
-3.99
x | P/E ratio 2025 * |
-3.81
x | Employees | 123 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.3% |
Latest transcript on Mersana Therapeutics, Inc.
1 day | +9.94% | ||
1 week | -21.68% | ||
Current month | -14.51% | ||
1 month | -27.15% | ||
3 months | -30.15% | ||
6 months | +123.97% | ||
Current year | +16.81% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 20-04-12 |
Director of Finance/CFO | 46 | 19-07-09 | |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 16-07-31 |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Anna Protopapas
BRD | Director/Board Member | 59 | 15-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | +2.72% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.71 | +9.94% | 2,807,159 |
24-05-09 | 2.465 | -27.50% | 3,772,154 |
24-05-08 | 3.4 | -3.55% | 876,321 |
24-05-07 | 3.525 | +0.71% | 679,630 |
24-05-06 | 3.5 | +1.16% | 694,529 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.81% | 332M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MRSN Stock